Mirxes
Signal active
Investment Firm
Overview
Mirxes is a biotechnology company that discovers, develops, and delivers accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases. The company's mission is to make diagnostic solutions for the early detection of diseases accessible on a global scale. It develops and commercializes accurate and non-invasive blood-based miRNA test kit products for the early detection of cancer and other diseases.
Highlights
Founded
2014
Industry
Biotechnology
Employees
251-500
Investment
1
Lead Investment
0
Exits
undefined
Stages
Early Stage Venture
Investor Type
N/A
Location
Asia
Contact Information
Social
Profile Resume
Mirxes, established in 2014 and headquartered in Asia., specializes in Early Stage Venture investments across Health Care, Financial Services, Venture Capital, Finance, Impact Investing, Biotechnology, Life Science, Biopharma, Medical Device, Neuroscience. Their recent investments include Med247, East Ventures, Altara Ventures, KK Fund, Ventura Ventures. The highest investment round they participated in was $342.0M. Among their most notable exits are Med247 and East Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Mirxes has made 1 investments. Their most recent investment was on Mar 31, 2022, when Med247 raised $4.5M.
investments
1
Diversity investments
0
Lead investments
0
Number of exits
undefined
Investments
1
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Mar 31, 2022 | Med247 | Health Care | 4.5M |
Exits
0
Funding Timeline
Funding rounds
1
Investors
14
Funds
0
Funding Rounds
1
Mirxes has raised 1 rounds. Their latest funding was raised on Mar 31, 2022 from a Series A - Med247 round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Mar 31, 2022 | Series A - Med247 | - | 4.5M | - |
Investors
19
Mirxes is funded by 19 investor(s). EDBI and Mitsui & Co Kantor are the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
China Fellow Partners | Yes | Series D - Mirxes | 50.0M |
The Agency for Science, Technology and Research | No | Series D - Mirxes | 50.0M |
Mitsui & Co | No | Series D - Mirxes | 50.0M |
EDBI | No | Series D - Mirxes | 50.0M |
The Agency for Science, Technology and ResearchFund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.